08.02.2021 | COVID-19 | Brief Report Open Access
Long-term sero-positivity for IgG, sequelae of respiratory symptoms, and abundance of malformed sperms in a patient recovered from severe COVID-19
Publisher’s note
Case presentation
Reference range
|
Jan 25
|
Jan 27
|
Jan 30
|
Feb 22
|
Mar 2
|
Mar 11
|
Jul 22
|
|
---|---|---|---|---|---|---|---|---|
WBC (× 10
9/L)
|
3.5–9.5
|
3.92
|
5.3
|
11.92
|
4.13
|
4.72
|
8.75
|
6.12
|
NEU#(× 10
9/L)
|
1.8–6.3
|
2.23
|
4.0
|
10.99
|
2.02
|
2.05
|
5.65
|
2.93
|
LYM#(× 10
9/L)
|
1.1–3.2
|
1.14
|
0.89
|
0.5
|
1.42
|
2.11
|
2.68
|
2.63
|
CRP (mg/L)
|
≤ 6
|
11.35
|
66.81
|
110.1
|
0.93
|
1.48
|
0.05
|
0.68
|
PCT (pg/mL)
|
≤ 0.046
|
0.098
|
0.101
|
0.13
|
< 0.020
|
0.028
|
-
|
-
|
ALT (U/L)
|
0–40
|
39.1
|
45.3
|
24.0
|
45.3
|
31.1
|
-
|
32.5
|
AST (U/L)
|
0–40
|
25.4
|
32.6
|
36.0
|
18.0
|
15.4
|
-
|
18.3
|
LDH (U/L)
|
120–250
|
242
|
349
|
245
|
6.2
|
-
|
-
|
190
|
HBDH (U/L)
|
72–182
|
181
|
284
|
206
|
480
|
-
|
-
|
165
|
CK (U/L)
|
50–310
|
158
|
234
|
71
|
202
|
-
|
-
|
189
|
CK-MB (U/L)
|
< 24
|
11.65
|
14.19
|
11.46
|
26
|
-
|
-
|
-
|
TP (g/L)
|
65–85
|
-
|
68.77
|
64.04
|
71.2
|
68.04
|
-
|
76.11
|
Alb (g/L)
|
40–55
|
-
|
43.8
|
38.5
|
28.7
|
41.9
|
-
|
51.8
|
Crea (μmol/L)
|
57–97
|
93.4
|
-
|
79.9
|
86.1
|
80.2
|
-
|
95.4
|
D-dimer (μg/mL)
|
0–0.5
|
-
|
-
|
Over linear
|
1.20
|
-
|
-
|
0.19
|
FDP (μg/mL)
|
0–5
|
-
|
-
|
2.5
|
3.14
|
-
|
-
|
0.7
|
FIB (g/L)
|
2–4
|
-
|
-
|
Over linear
|
2.93
|
-
|
-
|
2.43
|
ESR (mm/h)
|
0–20
|
-
|
-
|
68.2
|
-
|
-
|
-
|
-
|
SaO2 (%)
|
95–98
|
95
|
90
|
85
|
99
|
98
|
98
|
-
|
GM test
|
Negative
|
-
|
-
|
Positive
|
-
|
-
|
-
|
-
|
G test (pg/mL)
|
< 37.5
|
-
|
-
|
> 95.0
|
-
|
-
|
-
|
|
MP-IgM
|
Negative
|
-
|
Positive
|
-
|
-
|
-
|
-
|
|
BNP (pg/mL)
|
0–125
|
-
|
-
|
290.2
|
-
|
-
|
-
|
|
Ferritin (ng/mL)
|
23.9–336.2
|
-
|
-
|
702.54
|
-
|
-
|
-
|
Jan-29
|
Jan-30
|
Feb-16
|
Mar-20
|
Apr-17
|
May-8
|
May-25
|
Jun-19
|
Jul-20
|
Reference range(COI)
|
Jul-20
|
Aug-27
|
Sep-29
|
Oct-30
|
Nov-30
|
Dec-30
|
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SARS CoV-2 RNA( throat swab)
|
-
|
+
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||
2019-nCoV-IgG (CGM)
|
+
|
none
|
none
|
+
|
+
|
+
|
+
|
+
|
+
|
|||||||
2019-nCoV-IgM (CGM)
|
+
|
none
|
none
|
+
|
-
|
-
|
-
|
-
|
-
|
|||||||
2019-nCoV-IgG(CLIA)
|
<1.0
|
8.17
|
5.84
|
8.30
|
7.87
|
8.12
|
10.37
|
|||||||||
2019-nCoV-IgM(CLIA)
|
<1.0
|
0.15
|
0.05
|
0.06
|
0.04
|
0.03
|
0.01
|
Reference range
|
Mar 28
|
|
---|---|---|
FEV1 (L)
|
3.245
|
2.656
|
VCmax (L)
|
3.907
|
3.494
|
FVC (L)
|
3.907
|
3.399
|
PEF (L/s)
|
9.41
|
7.84
|
IC (L)
|
2.923
|
2.554
|
FEF25 (L/s)
|
7.5
|
7.86
|
FEF50 (L/s)
|
4.37
|
3.55
|
FEF75 (L/s)
|
1.82
|
0.67
|
MMEF
|
4.07
|
2.31
|
MEP (cmH
2O)
|
237
|
156
|
MIP (cmH
2O)
|
126
|
80
|
MV (L)
|
10.714
|
8.161
|
ERV (L)
|
1.408
|
0.793
|
Apnea hypopnea index
|
< 5
|
8.53
|
Oxyhemoglobin saturation(%)
|
95–98
|
92
|
Reference range
|
Results
|
|
---|---|---|
Sperm morphology report
|
||
Jun 22
|
||
Total sperm number analyzed
|
227
|
|
Normal sperm (%)
|
4
|
3.52
|
Malformed sperm rate(%)
|
96.48
|
|
Total number of abnormal
|
322
|
|
Head malformation (%)
|
96.47
|
|
Neck and midpiece malformation (%)
|
35.68
|
|
Tail malformation (%)
|
9.69
|
|
Sex hormone test
|
||
LH (mIU/mL)
|
1.7–8.6
|
6.23
|
FSH (mIU/mL)
|
1.5–12.4
|
4.95
|
Estradiol (pg/mL)
|
11.3–43.2
|
24.21
|
Prolactin (ng/mL)
|
4.05–15.2
|
17.53
|
Testosterone (ng/mL)
|
2.49–8.36
|
3.26
|
Sperm activity
|
||
Jul 26
|
||
pH
|
≥ 7.2
|
7.8
|
Semen volume (mL)
|
≥ 1.5
|
3.5
|
Liquefaction time (min)
|
≤ 60
|
15
|
Sperm concentration (× 106/mL)
|
≥ 15
|
7.9
|
PR+NP (%)
|
≥ 40
|
43.5
|
PR%
|
≥ 32.0
|
25.0
|
NP%
|
1
|
18.5
|
IM%
|
22
|
56.5
|
VAP (mm/s)
|
26.6
|
|
VCL (mm/s)
|
41.8
|
|
VSL (mm/s)
|
22.7
|
|
LIN (%)
|
42.6
|
|
Survival rate (%) (eosin-aniline black stain)
|
≥ 58
|
80
|